Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03559725 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes
A Phase 1 study, sponsored by 22nd Century Group.
- Completed
- Registry status
- Phase 1
- Development phase
- 55
- Enrollment target
NCT03559725: Completed Phase 1 study, sponsored by 22nd Century Group.
NCT03559725 is a Phase 1 study that has completed, run by 22nd Century Group. The registered enrollment target is 55 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03559725, a Phase 1 study, has completed, sponsored by 22nd Century Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study is designed to evaluate the abuse liability of mentholated very low nicotine cigarettes compared to nicotine gum and usual brand cigarettes.
Interventions
- DRUG Nicotine gum (C)
- OTHER VLN menthol cigarettes (A)
- OTHER Usual Brand Menthol Cigarettes (B)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2018-10-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03559725
The ClinicalTrials.gov registry entry for NCT03559725 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. The listed sponsor is 22nd Century Group, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine gum (C) is the first listed.
NCT03559725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03559725 about?
NCT03559725 is a clinical study titled "Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes". This study is designed to evaluate the abuse liability of mentholated very low nicotine cigarettes compared to nicotine gum and usual brand cigarettes.
What is the current status of trial NCT03559725?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 55 participants. The study started on 2018-05-01. Estimated completion is 2018-10-04.
What interventions are being tested in trial NCT03559725?
The interventions under investigation include: Nicotine gum (C) (DRUG), VLN menthol cigarettes (A) (OTHER), Usual Brand Menthol Cigarettes (B) (OTHER).
Who is sponsoring clinical trial NCT03559725?
This trial is sponsored by 22nd Century Group, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.